Hepatotoxicity
This medicine may affect the liver.
Leaflet NIMELID 100mg granules for oral suspension
- Product code:
- W61456003
- Quantity:
- 30
- Indicated for:
- pain and inflammation
- Route of administration:
- oral
- Substance:
- nimesulide (nonsteroidal anti-inflammatory drug)
- ATC
- M01AX17 — Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Nephrotoxicity
This medicine may affect the kidneys.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Ulcer / gastrointestinal bleeding
This medicine may increase the risk of ulcer or gastrointestinal bleeding.
Nimesulide is a nonsteroidal anti-inflammatory drug (NSAID) used to treat acute pain, inflammation, and fever. It is indicated for conditions such as muscle pain, joint pain, arthritis, dysmenorrhea (menstrual pain), and other types of acute pain. Nimesulide works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, thereby reducing the production of prostaglandins, substances involved in inflammation and pain.
It is administered orally, usually in the form of tablets or granules for suspension, with a recommended dose of 100 mg twice daily, after meals, to minimize the risk of gastric irritation. The duration of treatment should be as short as possible, typically no longer than 15 days.
Common side effects include nausea, vomiting, diarrhea, abdominal pain, and dizziness. In rare cases, it may cause more serious reactions, such as liver damage, severe allergic reactions, or gastrointestinal disorders like ulcers or bleeding.
Nimesulide is contraindicated in patients with severe liver impairment, severe kidney impairment, active gastric ulcers, gastrointestinal bleeding, or hypersensitivity to the drug. It is also not recommended for children under 12 years of age, pregnant women, or breastfeeding mothers. Patients should follow their doctor's recommendations and not exceed the prescribed dose.
It is administered orally, usually in the form of tablets or granules for suspension, with a recommended dose of 100 mg twice daily, after meals, to minimize the risk of gastric irritation. The duration of treatment should be as short as possible, typically no longer than 15 days.
Common side effects include nausea, vomiting, diarrhea, abdominal pain, and dizziness. In rare cases, it may cause more serious reactions, such as liver damage, severe allergic reactions, or gastrointestinal disorders like ulcers or bleeding.
Nimesulide is contraindicated in patients with severe liver impairment, severe kidney impairment, active gastric ulcers, gastrointestinal bleeding, or hypersensitivity to the drug. It is also not recommended for children under 12 years of age, pregnant women, or breastfeeding mothers. Patients should follow their doctor's recommendations and not exceed the prescribed dose.
General data about NIMELID 100mg
- Substance:
- nimesulide
- Date of latest medicines list:
- 01-03-2024
- Product code:
- W61456003
- Concentration:
- 100mg
- Pharmaceutical form:
- granules for oral suspension
- Quantity:
- 30
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for nimesulide
Concentrations available for nimesulide
- 100mg
- 30mg/g